Actively Recruiting
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Led by Amryt Pharma · Updated on 2025-07-03
12
Participants Needed
12
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an Open Label, Phase IV, Post Authorisation Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in people with Partial Lipodystrophy
CONDITIONS
Official Title
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of familial or acquired partial lipodystrophy
You will not qualify if you...
- Treatment with any Investigational Medicinal Product within 6 months or 5 times the terminal half-life of the corresponding IMP, whichever is longer, before the screening visit.
- Other protocol defined inclusion/exclusion criteria apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez
Lille, France
Actively Recruiting
2
Hopital Pitie-Salpetriere
Paris, France
Actively Recruiting
3
Hôpital Saint-Antoine
Paris, France
Actively Recruiting
4
Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
Actively Recruiting
5
Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM)
Berlin, Germany
Actively Recruiting
6
Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin
Ulm, Germany
Not Yet Recruiting
7
Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi
Bologna, Italy
Actively Recruiting
8
Universitá degli Studi "Magna Graecia" di Catanzaro
Catanzaro, Italy
Not Yet Recruiting
9
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara
Novara, Italy
Actively Recruiting
10
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello
Pisa, Italy
Actively Recruiting
11
A.S.U Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia
Udine, Italy
Actively Recruiting
12
Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital
Cambridge, United Kingdom
Not Yet Recruiting
Research Team
J
Janet Boylan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here